Related Articles
Read Mirova’s monthly market review and outlook for listed assets.
Mirova's annual market review and 2024 outlook for private assets.
Mirova's annual market review and 2024 outlook for listed assets.
Compelling AI applications, renewable energy recovery, and pharma developments are considered for 2024 by Jens Peers.